Clinical Trial Update: Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion

View source ↗

Summary

A clinical trial update evaluating the safety and efficacy of GENOSS DCB with a shellac plus vitamin E excipient for de novo coronary lesions in coronary artery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Genoss DCB (paclitaxel-coated balloon)

Snippet

Sponsor: Genoss Co., Ltd. | Conditions: Coronary Artery Disease(CAD) | Status: ENROLLING_BY_INVITATION